Aug 1
|
Appian, Resideo, Bitfarms, and More Stocks See Action From Activist Investors
|
Jul 30
|
ZimVie Reports Second Quarter 2025 Financial Results
|
Jul 25
|
ZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025
|
Jul 23
|
ZimVie Announces Exclusive Distribution Agreement with Osstem Implant to Expand Premium Dental Implant Offering in China
|
Jul 22
|
ARCHIMED to acquire life sciences company ZimVie for $730m
|
Jul 22
|
ZimVie to sell to investment firm for about $730M
|
Jul 21
|
ZimVie Doubles — And Then Some — On Its Second Takeover Deal
|
Jul 21
|
ZimVie to Be Taken Private by Archimed in $730 Million Buyout Deal
|
Jul 21
|
ZimVie Announces Definitive Agreement to be Acquired by ARCHIMED for $19.00 Per Share in Cash
|
Jul 16
|
ZimVie (ZIMV) Announces the Launch of its RealGUIDE Software Suite and Implant Concierge Service in Japan
|
May 9
|
Q1 2025 ZimVie Inc Earnings Call
|
May 9
|
ZimVie Inc (ZIMV) Q1 2025 Earnings Call Highlights: Navigating Challenges with Strategic Growth ...
|
May 8
|
ZimVie Reports First Quarter 2025 Financial Results
|
Apr 21
|
ZimVie Pioneers the Future of Molar Restoration with New Immediate Molar Dental Implant System
|
Feb 12
|
ZimVie to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025
|
Jul 23
|
ZimVie Announces FDA Clearance and U.S. Launch of GenTek® Restorative Components
|
Jun 26
|
Zimvie mulls sale after takeover approaches: Bloomberg
|
Jun 25
|
Dental Implant Maker ZimVie Weighs Potential Sale
|
May 16
|
ZimVie to Participate in Upcoming Investor Conferences
|
May 12
|
ZimVie Inc. (NASDAQ:ZIMV) Q1 2024 Earnings Call Transcript
|